124 related articles for article (PubMed ID: 37984714)
1. Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry.
Ballas L; Ailawadhi S; Narang M; Gasparetto CJ; Lee HC; Hardin JW; Durie BGM; Toomey K; Omel J; Wagner LI; Abonour R; Terebelo HR; Joshi P; Yu E; Liu L; Rifkin RM; Jagannath S
Pract Radiat Oncol; 2024; 14(2):e141-e149. PubMed ID: 37984714
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Development of a prognostic model for overall survival in multiple myeloma using the Connect
Terebelo HR; Abonour R; Gasparetto CJ; Toomey K; Durie BGM; Hardin JW; Jagannath S; Wagner L; Narang M; Flick ED; Srinivasan S; Yue L; Kitali A; Agarwal A; Rifkin RM;
Br J Haematol; 2019 Dec; 187(5):602-614. PubMed ID: 31382320
[TBL] [Abstract][Full Text] [Related]
4. Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States.
Medhekar R; Ran T; Fu AZ; Patel S; Kaila S
BMC Cancer; 2022 Aug; 22(1):901. PubMed ID: 35982416
[TBL] [Abstract][Full Text] [Related]
5. Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Ailawadhi S; Jagannath S; Lee HC; Narang M; Rifkin RM; Terebelo HR; Durie BGM; Toomey K; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; He M; Yue L; Flick ED; Agarwal A; Abonour R;
Cancer; 2020 Oct; 126(19):4332-4340. PubMed ID: 32706404
[TBL] [Abstract][Full Text] [Related]
6. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
[TBL] [Abstract][Full Text] [Related]
7. Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry.
Rifkin RM; Jagannath S; Durie BGM; Narang M; Terebelo HR; Gasparetto CJ; Toomey K; Hardin JW; Wagner L; Parikh K; Abouzaid S; Srinivasan S; Kitali A; Zafar F; Abonour R
Clin Ther; 2018 Jul; 40(7):1193-1202.e1. PubMed ID: 30007443
[TBL] [Abstract][Full Text] [Related]
8. Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.
Abonour R; Wagner L; Durie BGM; Jagannath S; Narang M; Terebelo HR; Gasparetto CJ; Toomey K; Hardin JW; Kitali A; Gibson CJ; Srinivasan S; Swern AS; Rifkin RM
Ann Hematol; 2018 Dec; 97(12):2425-2436. PubMed ID: 30056582
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
[TBL] [Abstract][Full Text] [Related]
10. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data.
Kaur G; Mejia Saldarriaga M; Shah N; Catamero DD; Yue L; Ashai N; Goradia N; Heisler J; Xiao Z; Ghalib N; Aaron T; Cole D; Foreman R; Mantzaris I; Derman O; Bachier L; Sica RA; Kornblum N; Braunschweig I; Shastri A; Goel S; Verma A; Janakiram M
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e384-e397. PubMed ID: 33339770
[TBL] [Abstract][Full Text] [Related]
11. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
Shah JJ; Abonour R; Gasparetto C; Hardin JW; Toomey K; Narang M; Srinivasan S; Kitali A; Zafar F; Flick ED; Rifkin RM
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):575-583.e2. PubMed ID: 28886839
[TBL] [Abstract][Full Text] [Related]
13. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
14. Connect MM Registry as a national reference for United States multiple myeloma patients.
Ailawadhi S; Jagannath S; Narang M; Rifkin RM; Terebelo HR; Toomey K; Durie BGM; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; Kumar V; Yue L; Kitali A; Agarwal A; Abonour R;
Cancer Med; 2020 Jan; 9(1):35-42. PubMed ID: 31701679
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
Lee HC; Ramasamy K; Weisel K; Abonour R; Hardin JW; Rifkin RM; Ailawadhi S; Terebelo HR; Durie BGM; Tang D; Joshi P; Liu L; Jou YM; Che M; Hernandez G; Narang M; Toomey K; Gasparetto C; Wagner LI; Jagannath S
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):112-122. PubMed ID: 36567211
[TBL] [Abstract][Full Text] [Related]
16. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
17. Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
Rifkin RM; Abonour R; Terebelo H; Shah JJ; Gasparetto C; Hardin J; Srinivasan S; Ricafort R; Nagarwala Y; Durie BG
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):368-76. PubMed ID: 25617035
[TBL] [Abstract][Full Text] [Related]
18. Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect
Abonour R; Rifkin RM; Gasparetto C; Toomey K; Durie BGM; Hardin JW; Terebelo HR; Jagannath S; Narang M; Ailawadhi S; Omel JL; Lee HC; Srinivasan S; Kitali A; Agarwal A; Wagner L;
Br J Haematol; 2021 Apr; 193(1):93-100. PubMed ID: 33118614
[TBL] [Abstract][Full Text] [Related]
19. Utilization Patterns of Single Fraction Radiation Therapy for Multiple Myeloma.
Resende Salgado L; Chang S; Ru M; Moshier E; Ghiassi-Nejad Z; Lazarev S; Smith W; Thompson M; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e238-e246. PubMed ID: 30904388
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
